Executive Cardiac Assessment Program
Michael Miyamoto, MD
Heart disease is the most common cause of death for both men and women. Often, the first symptom or sign of heart disease is a heart attack or other catastrophic heart event. Coronary artery disease can develop without symptoms for many years, and may only become manifest when atherosclerotic plaque progresses to the point where blood flow to the heart muscle is limited, causing symptoms (chest pain, angina pectoris) or heart attack (myocardial infarction).
Heart CT scan with calcium deposits indicating the presence of atherosclerotic plaque (arrow).
Fortunately, methods exist to detect individuals at risk for coronary artery disease. By identifying those with risk factors for heart disease, preventive measures may be undertaken, to avoid future heart events. Also, heart imaging tests are available to aid in the detection of early coronary artery disease, even years before any symptoms develop. For example, a simple CT scan of the heart can detect and quantify artery calcium deposits, which are markers of the presence of atherosclerotic plaque.
The Executive Cardiac Assessment Program has been designed to identify those with risk factors for heart disease and/or signs of coronary atherosclerosis. Individuals who may benefit from the assessment include men and women with known risk factors for heart disease (high blood pressure, high cholesterol, diabetes, smoking, family history of heart disease), as well as those simply seeking a thorough, baseline cardiac evaluation. Some may want to augment their regular general physical examinations with a more in-depth heart examination.
Corporations may refer members of their executive teams and other key employees, as part of an optimal health management strategy. A relatively small but important investment in the cardiac health of the people who make up a company may ultimately pay multiple dividends, economic and medical.
The Executive Cardiac Assessment includes:
- Office consultation with Dr. Miyamoto, focused on heart history and physical examination
- 12-lead electrocardiogram (EKG)
- Blood assessment including: fasting cholesterol panel, diabetes testing, high-sensitivity C-reactive protein
- Cardioscan - a rapid heart CT scan to detect signs of early artery plaque, even prior to symptoms developing
- A follow-up visit with Dr. Miyamoto to review the significance of your results
- Comprehensive consultation report with personalized recommendations
- Parking validation
Cost of the Assessment:
The all-inclusive fee is $950, payable prior to or at the first consultation visit*. Depending on your health insurance plan, you might be able to apply for partial reimbursement of the fee, on your own.
The fee is a small investment in one’s heart health, where early identification of risk factors and early heart disease may allow for the initiation of simple measures that can help to prevent future heart problems.
* Corporate and family discounts may be available
To Schedule your Cardiac Assessment:
Please call Dr. Miyamoto’s office at (949) 364-3388 or email heartcheck@MHMG.com.
Every effort will be made to expedite your evaluation and accommodate your schedule.
If possible, please fast for approximately 10 hours prior to your initial office consultation (water, medicines are okay), to allow for lab testing.
Often, your Cardioscan (heart CT) can be scheduled for the same day as your initial office consultation.
If you choose, all of your results and reports can be sent to your primary physician.
The office is located in the Mission Medical Plaza, (corner of Crown Valley Parkway and Medical Center Drive), 26800 Crown Valley Parkway, Suite 120, Mission Viejo, CA 92691.
Michael Miyamoto, M.D.
Fellow, American College of Cardiology
Education and Training:
B.A.S., M.S., Stanford University
M.D., UCSD School of Medicine
Internship and Residency, Internal Medicine, Massachusetts General Hospital
Cardiology and Heart Failure/Transplant Fellowship, Massachusetts General Hospital, Harvard Medical School